SCHEMBL10551346

SCHEMBL10551346

Cc1cc(=O)[nH]nc1-c1ccc(-n2ccnc2)nc1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE3B Q13370 4/20 0.70
▸ PDE3A Q14432 4/20 0.70
▸ PIM1 P11309 3/20 0.48
▸ ADH5 P11766 5/20 0.43
▸ EGLN2 Q96KS0 1/20 0.41
▸ GAA P10253 1/20 0.40
▸ CLK4 Q9HAZ1 2/20 0.39
▸ MET P08581 1/20 0.39
▸ PDGFRB P09619 1/20 0.39
▸ CDK8 P49336 1/20 0.39
▸ ROCK1 Q13464 1/20 0.39
▸ NTRK3 Q16288 1/20 0.39
▸ NTRK2 Q16620 1/20 0.39
▸ AURKB Q96GD4 1/20 0.39
▸ PDE2A O00408 1/20 0.38
▸ CYP1A2 P05177 3/20 0.38
▸ CYP3A4 P08684 3/20 0.38
▸ CYP2D6 P10635 3/20 0.38
▸ CYP2C19 P33261 3/20 0.38
▸ HRH3 Q9Y5N1 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7290528 0.83 PDE3B (1.00) PDE3BPDE3AADH5ROCK1PDE2A
SCHEMBL10553489 0.79 PDE3B (0.69) PDE3BPDE3APIM1ADH5CLK4
SCHEMBL10353678 0.72 PDE3B (0.63) PDE3BPDE3ACLK4METPDGFRB
SCHEMBL10645524 0.72 PDE3B (0.61) PDE3BPDE3APIM1ADH5EGLN2
SCHEMBL7276956 0.70 PDE3B (0.59) PDE3BPDE3APIM1ADH5PDE2A
SCHEMBL10649130 0.70 PDE3B (0.65) PDE3BPDE3AADH5PDE2A
SCHEMBL10631471 0.69 KMT2A (0.40) PDE3BPDE3APIM1ADH5EGLN2
SCHEMBL10551860 0.68 PDE3B (0.46) PDE3BPDE3APIM1ADH5GAA
SCHEMBL8815628 0.68 GAA (0.50) PIM1EGLN2GAACLK4CYP1A2
SCHEMBL10468163 0.68 PDE3A (0.70) PDE3BPDE3APIM1GAACLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4847251-A CARDIOVASCULAR DISORDERS BOEHRINGER MANNHEIM GMBH (DE) 1989-07-11 — — US disclosed
EP-0255704-A2 Pyridazinone derivatives, process for their preparation and their use as medicines Roche Diagnostics GmbH (DE) 1988-02-10 — — EP disclosed
Send feedback